These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38814720)

  • 21. Eleven-month SARS-CoV-2 binding antibody decay, and associated factors, among mRNA vaccinees: implications for booster vaccination.
    Asamoah-Boaheng M; Grunau B; Haig S; Karim ME; Kirkham T; Lavoie PM; Sediqi S; Drews SJ; O'Brien SF; Barakauskas V; Marquez AC; Jassem A; Goldfarb DM
    Access Microbiol; 2023; 5(11):. PubMed ID: 38074111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COVID-19 Vaccine Hesitancy among French People Living with HIV.
    Vallée A; Fourn E; Majerholc C; Touche P; Zucman D
    Vaccines (Basel); 2021 Mar; 9(4):. PubMed ID: 33804808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort study.
    Gray KJ; Bordt EA; Atyeo C; Deriso E; Akinwunmi B; Young N; Baez AM; Shook LL; Cvrk D; James K; De Guzman R; Brigida S; Diouf K; Goldfarb I; Bebell LM; Yonker LM; Fasano A; Rabi SA; Elovitz MA; Alter G; Edlow AG
    Am J Obstet Gynecol; 2021 Sep; 225(3):303.e1-303.e17. PubMed ID: 33775692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative immunogenicity of an mRNA/LNP and a DNA vaccine targeting HIV
    Valentin A; Bergamaschi C; Rosati M; Angel M; Burns R; Agarwal M; Gergen J; Petsch B; Oostvogels L; Loeliger E; Chew KW; Deeks SG; Mullins JI; Pavlakis GN; Felber BK
    Front Immunol; 2022; 13():945706. PubMed ID: 35935984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Cocktail of Lipid Nanoparticle-mRNA Vaccines Broaden Immune Responses against β-Coronaviruses in a Murine Model.
    Zhang Y; Zhang J; Li D; Mao Q; Li X; Liang Z; He Q
    Viruses; 2024 Mar; 16(3):. PubMed ID: 38543849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Naturally Acquired Immunity versus Vaccine-induced Immunity, Reinfections versus Breakthrough Infections: A Retrospective Cohort Study.
    Gazit S; Shlezinger R; Perez G; Lotan R; Peretz A; Ben-Tov A; Herzel E; Alapi H; Cohen D; Muhsen K; Chodick G; Patalon T
    Clin Infect Dis; 2022 Aug; 75(1):e545-e551. PubMed ID: 35380632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody titer after administration of mRNA-based vaccine against severe acute respiratory syndrome coronavirus 2 in liver transplant recipients.
    Mita A; Ohno Y; Masuda Y; Yoshizawa K; Kubota K; Notake T; Shimizu A; Matsunami H; Soejima Y
    Ann Gastroenterol Surg; 2023 Sep; 7(5):800-807. PubMed ID: 37663964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Limited Humoral and Specific T-Cell Responses After SARS-CoV-2 Vaccination in PWH With Poor Immune Reconstitution.
    Benet S; Blanch-Lombarte O; Ainsua-Enrich E; Pedreño-Lopez N; Muñoz-Basagoiti J; Raïch-Regué D; Perez-Zsolt D; Peña R; Jiménez E; Rodríguez de la Concepción ML; Ávila C; Cedeño S; Escribà T; Romero-Martín L; Alarcón-Soto Y; Rodriguez-Lozano GF; Miranda C; González S; Bailón L; Blanco J; Massanella M; Brander C; Clotet B; Paredes R; Esteve M; Izquierdo-Useros N; Carrillo J; Prado JG; Moltó J; Mothe B
    J Infect Dis; 2022 Nov; 226(11):1913-1923. PubMed ID: 36200261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis.
    McElrath MJ; De Rosa SC; Moodie Z; Dubey S; Kierstead L; Janes H; Defawe OD; Carter DK; Hural J; Akondy R; Buchbinder SP; Robertson MN; Mehrotra DV; Self SG; Corey L; Shiver JW; Casimiro DR;
    Lancet; 2008 Nov; 372(9653):1894-1905. PubMed ID: 19012957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Humoral and Cellular Immune Response Elicited by Two Doses of mRNA BNT162b2 Vaccine Against SARS-CoV-2 in People Living with HIV.
    Vanetti C; Milazzo L; Ardizzone F; Oreni L; Cappelletti G; Trabattoni D; Biasin M
    AIDS Res Hum Retroviruses; 2023 Sep; 39(9):495-499. PubMed ID: 37031355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunogenicity to COVID-19 mRNA vaccine third dose in people living with HIV.
    Vergori A; Cozzi Lepri A; Cicalini S; Matusali G; Bordoni V; Lanini S; Meschi S; Iannazzo R; Mazzotta V; Colavita F; Mastrorosa I; Cimini E; Mariotti D; De Pascale L; Marani A; Gallì P; Garbuglia A; Castilletti C; Puro V; Agrati C; Girardi E; Vaia F; Antinori A;
    Nat Commun; 2022 Aug; 13(1):4922. PubMed ID: 35995780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune response to mRNA-based COVID-19 booster vaccination in people living with HIV.
    Malin JJ; Suárez I; Biehl LM; Schommers P; Knops E; Di Cristanziano V; Heger E; Pflieger E; Wyen C; Bettin D; Rybniker J; Fätkenheuer G; Lehmann C
    HIV Med; 2023 Jul; 24(7):785-793. PubMed ID: 36883641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Single Dose SARS-CoV-2 Replicon RNA Vaccine Induces Cellular and Humoral Immune Responses in Simian Immunodeficiency Virus Infected and Uninfected Pigtail Macaques.
    O'Connor MA; Erasmus JH; Randall S; Archer J; Lewis TB; Brown B; Fredericks M; Groenier S; Iwayama N; Ahrens C; Garrison W; Wangari S; Guerriero KA; Fuller DH
    Front Immunol; 2021; 12():800723. PubMed ID: 34992610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interactions between the HIV-1 Unspliced mRNA and Host mRNA Decay Machineries.
    Toro-Ascuy D; Rojas-Araya B; Valiente-Echeverría F; Soto-Rifo R
    Viruses; 2016 Nov; 8(11):. PubMed ID: 27886048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitigating Coronavirus Induced Dysfunctional Immunity for At-Risk Populations in COVID-19: Trained Immunity, BCG and "New Old Friends".
    Kleen TO; Galdon AA; MacDonald AS; Dalgleish AG
    Front Immunol; 2020; 11():2059. PubMed ID: 33013871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status.
    Neidleman J; Luo X; McGregor M; Xie G; Murray V; Greene WC; Lee SA; Roan NR
    Elife; 2021 Oct; 10():. PubMed ID: 34636722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. mRNA vaccines and hybrid immunity use different B cell germlines against Omicron BA.4 and BA.5.
    Andreano E; Paciello I; Pierleoni G; Maccari G; Antonelli G; Abbiento V; Pileri P; Benincasa L; Giglioli G; Piccini G; De Santi C; Sala C; Medini D; Montomoli E; Maes P; Rappuoli R
    Nat Commun; 2023 Mar; 14(1):1734. PubMed ID: 36977711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evolution of long-term vaccine-induced and hybrid immunity in healthcare workers after different COVID-19 vaccine regimens.
    Moore SC; Kronsteiner B; Longet S; Adele S; Deeks AS; Liu C; Dejnirattisai W; Reyes LS; Meardon N; Faustini S; Al-Taei S; Tipton T; Hering LM; Angyal A; Brown R; Nicols AR; Dobson SL; Supasa P; Tuekprakhon A; Cross A; Tyerman JK; Hornsby H; Grouneva I; Plowright M; Zhang P; Newman TAH; Nell JM; Abraham P; Ali M; Malone T; Neale I; Phillips E; Wilson JD; Murray SM; Zewdie M; Shields A; Horner EC; Booth LH; Stafford L; Bibi S; Wootton DG; Mentzer AJ; Conlon CP; Jeffery K; Matthews PC; Pollard AJ; Brown A; Rowland-Jones SL; Mongkolsapaya J; Payne RP; Dold C; Lambe T; Thaventhiran JED; Screaton G; Barnes E; Hopkins S; Hall V; Duncan CJA; Richter A; Carroll M; de Silva TI; Klenerman P; Dunachie S; Turtle L;
    Med; 2023 Mar; 4(3):191-215.e9. PubMed ID: 36863347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cluster Analysis Identifies Distinct Patterns of T-Cell and Humoral Immune Responses Evolution Following a Third Dose of SARS-CoV-2 Vaccine in People Living with HIV.
    El Moussaoui M; Desmecht S; Lambert N; Maes N; Braghini J; Marechal N; Quintana C; Briquet K; Gofflot S; Toussaint F; Hayette MP; Vermeersch P; Lutteri L; Grégoire C; Beguin Y; Rahmouni S; Moutschen M; Desmecht D; Darcis G
    Viruses; 2023 Jun; 15(7):. PubMed ID: 37515123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence and determinants to COVID-19 vaccine hesitancy among people living with HIV in Bench Sheko zone, Southwest Ethiopia: A multi-center study.
    Alie MS; Abebe GF; Negesse Y; Gichew S
    Heliyon; 2024 Mar; 10(6):e27901. PubMed ID: 38496901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.